Composition:
Examiné médicalement par Fedorchenko Olga Valeryevna, Pharmacie Dernière mise à jour le 07.04.2022
Attention! Information sur la page est réservée aux professionnels de la santé! Les informations sont collectées dans des sources ouvertes et peuvent contenir des erreurs significatives! Soyez prudent et revérifiez toutes les informations de cette page!
Top 20 des médicaments avec les mêmes ingrédients:
Deselex is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with:
- allergic rhinitis
- urticaria
Deselex is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with:
- allergic rhinitis
- urticaria.
Posology
Adults and adolescents (12 years of age and over)
The recommended dose of Deselex is one tablet once a day.
Intermittent allergic rhinitis (presence of symptoms for less than 4 days per week or for less than 4 weeks) should be managed in accordance with the evaluation of patient's disease history and the treatment could be discontinued after symptoms are resolved and reinitiated upon their reappearance.
In persistent allergic rhinitis (presence of symptoms for 4 days or more per week and for more than 4 weeks), continued treatment may be proposed to the patients during the allergen exposure periods.
Paediatric population
There is limited clinical trial efficacy experience with the use of desloratadine in adolescents 12 through 17 years of age.
The safety and efficacy of Deselex 5 mg film-coated tablets in children below the age of 12 years have not been established. No data are available.
Method of administration
Oral use.
The dose can be taken with or without food.
Posology
Adults and adolescents 12 years of age and over.
The recommended dose of Deselex oral solution is 10ml (5mg) oral solution once a day.
Paediatric Population
The prescriber should be aware that most cases of rhinitis below 2 years of age are of infectious origin and there are no data supporting the treatment of infectious rhinitis with Deselex oral solution.
Children 1 through 5 years of age: 2.5 ml (1.25 mg) Deselex oral solution once a day.
Children 6 through 11 years of age: 5 ml (2.5 mg) Deselex oral solution once a day.
The safety and efficacy of Deselex 0.5mg/ml oral solution in children below the age of 1 year have not been established. No data are available.
There is limited clinical trial efficacy experience with the use of Deselex in children 1 through 11 years of age and adolescents 12 through 17 years of age.
Intermittent allergic rhinitis (presence of symptoms for less than 4 days per week or for less than 4 weeks) should be managed in accordance with the evaluation of patient's disease history and the treatment could be discontinued after symptoms are resolved and reinitiated upon their reappearance.
In persistent allergic rhinitis (presence of symptoms for 4 days or more per week and for more than 4 weeks), continued treatment may be proposed to the patients during the allergen exposure periods.
Method of Administration
Oral use.
The dose can be taken with or without food.
However, we will provide data for each active ingredient